News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FAES Farma and Invida (a Menarini Group Company) Announce Agreement to Commercialize Bilastine in 17 Markets in Asia – Pacific


4/27/2012 10:01:27 AM

MADRID & SINGAPORE--(BUSINESS WIRE)--FAES FARMA, a leading Spanish pharmaceutical group dedicated to research, development, manufacturing and marketing of pharmaceuticals, and INVIDA Holdings Private Limited, a Member of the MENARINI Group and leading specialty biopharmaceutical company focused on the Asia Pacific region, are pleased to announce the signing of an exclusive long-term agreement to commercialize bilastine in 17 markets in Asia Pacific.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES